Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome.

DISCUSSION: Spironolactone use upfront in AHF patients at high risk for cardiorenal syndrome is safe and increases natriuresis.
PMID: 29587582 [PubMed - as supplied by publisher]

Source: Acta Cardiologica - March 29, 2018 Category: Cardiology Tags: Acta Cardiol Source Type: research